All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

A 55-year-old man with a history of poorly controlled type 2 diabetes mellitus presents to the emergency department with 4 days of worsening lower back pain. He initially attributed the discomfort to lifting a heavy box at work, but the pain has become progressively severe, is unremitting even at rest, and occasionally awakens him from sleep. His temperature is 37.8°C (100.0°F), blood pressure is 135/85 mmHg, and heart rate is 92/min. The physician is evaluating whether an immediate MRI of the lumbar spine is indicated. Which of the following physical examination findings represent 'red flags' that would specifically dictate the need for urgent spinal imaging to evaluate for severe neurologic compromise or deep space infection? (Select the correct options)

Select all that apply

Decreased resting tone of the external anal sphincter on digital rectal examination

Reproduction of pain radiating down the posterior thigh upon passive straight leg raising at 40 degrees

Focal, severe point tenderness to direct percussion over the L3 and L4 spinous processes

Localized pain in the lumbar paraspinal musculature that worsens with active range of motion

Bilaterally absent Achilles tendon reflexes in the absence of acute motor weakness

Show answer & explanation

Answer: Decreased resting tone of the external anal sphincter on digital rectal examination; Focal, severe point tenderness to direct percussion over the L3 and L4 spinous processes

Answer

The critical physical examination findings that mandate urgent spinal imaging are decreased resting tone of the external anal sphincter and focal, severe point tenderness to direct percussion over the spinous processes.

The correct physical examination findings that represent true clinical 'red flags' are decreased resting tone of the external anal sphincter and focal, severe point tenderness to direct percussion over the spinous processes. Decreased anal sphincter tone is a classic sign of cauda equina syndrome, a surgical emergency caused by compression of the lumbosacral nerve roots. Focal spinous process tenderness, especially in a diabetic patient presenting with unremitting pain at rest and a low-grade fever, is highly suspicious for vertebral osteomyelitis or a spinal epidural abscess. Both of these examination findings mandate an immediate MRI of the spine to facilitate definitive diagnosis and prompt intervention.

Step-by-Step Solution

Analyze the patient's presentation and baseline risk factors.

The patient has progressive back pain that is unremitting at rest and a history of poorly controlled diabetes.

Identifying baseline risk factors (diabetes) and atypical pain patterns (pain at rest, awakening from sleep) increases the pre-test probability for dangerous underlying etiologies.

Evaluate the clinical indications for obtaining an urgent lumbar spine MRI.

Urgent imaging is reserved for patients exhibiting clinical 'red flags' for cauda equina syndrome, spinal cord compression, or spinal infection.

Routine imaging for uncomplicated mechanical back pain or simple radiculopathy leads to unnecessary costs and potential over-treatment.

Identify the physical examination findings that constitute neurologic or infectious red flags.

Loss of anal sphincter tone correlates with cauda equina syndrome, while focal spinous process percussion tenderness correlates with deep space spinal infection. Both demand immediate advanced imaging.

These specific signs directly correlate with severe, irreversible neurologic compromise or deep space infection if not rapidly diagnosed and treated.

Key Concept

In patients presenting with acute lower back pain, the physical examination must focus on identifying 'red flags'—such as focal neurologic deficits (decreased sphincter tone, saddle anesthesia) or signs of deep infection (focal spinous process percussion tenderness)—which differentiate emergent conditions requiring immediate MRI from benign mechanical causes.

Question 1482Question →

While picnicking at a local park, a 28-year-old man sustains multiple bee stings and rapidly develops a diffuse urticarial rash, lip swelling, and severe shortness of breath. Paramedics transport him to the emergency department. Upon arrival, he is in profound respiratory distress with audible stridor. Vital signs show a heart rate of 135/min, blood pressure of 75/40 mm Hg, and oxygen saturation of 89% on room air. Lung auscultation reveals diffuse expiratory wheezing. A severe type I immunoglobulin E (IgE)-mediated hypersensitivity reaction is recognized.

Arrange the following therapeutic interventions in the most appropriate chronological sequence for the step-wise management of this patient's systemic immunologic reaction.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing severe anaphylactic shock is: 1) Initial intramuscular epinephrine, 2) Intravenous fluid resuscitation, 3) Repeat intramuscular epinephrine, 4) Intravenous epinephrine infusion, and 5) Adjunctive steroids and antihistamines.

The precise immunologic timeline of anaphylaxis requires rapid reversal of mast cell degranulation effects. Intramuscular epinephrine provides the optimal balance of rapid onset and safety. Fluid resuscitation treats the subsequent distributive shock. Escalating doses (repeat IM, then IV infusion) meet the ongoing cardiovascular demand. Finally, slower-acting agents (steroids/antihistamines) are given to blunt the late-phase inflammatory response.

Step-by-Step Solution

Administer initial intramuscular epinephrine.

Epinephrine binds to alpha-1, beta-1, and beta-2 receptors, counteracting the immunologic cascade by inducing vasoconstriction and bronchodilation.

This is the single most effective intervention for anaphylaxis and must be given immediately upon recognition to prevent fatal cardiovascular collapse or airway obstruction.

Provide aggressive volume resuscitation.

Intravenous crystalloid boluses are administered rapidly.

Systemic mast cell degranulation causes massive capillary leak and distributive shock, requiring large volumes of fluids to maintain preload while epinephrine exerts its effects.

Re-evaluate and administer a second dose of intramuscular epinephrine.

A repeat IM dose is given if the patient remains in shock or severe distress after 5 to 15 minutes.

Up to 20% of anaphylaxis cases require more than one dose of IM epinephrine due to severe ongoing mediator release from the type I hypersensitivity reaction.

Escalate to a continuous vasopressor infusion.

An intravenous epinephrine infusion is started.

When anaphylaxis is refractory to repeated IM epinephrine and adequate fluid boluses, a titratable IV infusion is necessary to maintain systemic vascular resistance.

Provide adjunctive immunomodulators.

Glucocorticoids (methylprednisolone) and H1-antihistamines (diphenhydramine) are administered.

These medications do not treat the acute life-threatening symptoms but help control cutaneous manifestations and may decrease the risk of a biphasic immunologic reaction 4 to 12 hours later.

Key Concept

The acute management of anaphylaxis follows a strict stepwise progression prioritizing interventions that immediately reverse life-threatening cardiopulmonary compromise (IM epinephrine, IV fluids), followed by escalation for refractory cases (IV epinephrine infusion), and finally adjunctive immunomodulators (steroids, antihistamines) to prevent delayed biphasic reactions.

Question 1483Question →

A 21-year-old man is brought to the emergency department by campus security due to severe agitation, confusion, and visual hallucinations. His friends report he ingested an unknown pill at a music festival three hours ago. Vital signs show a temperature of 38.9°C (102.0°F), blood pressure of 165/95 mmHg, heart rate of 132/min, and respiratory rate of 20/min. The attending physician is attempting to differentiate between a sympathomimetic toxidrome (e.g., cocaine, amphetamines) and an anticholinergic toxidrome (e.g., diphenhydramine, Jimson weed) based solely on the physical examination.

Which of the following physical examination findings would specifically establish a diagnosis of anticholinergic toxicity rather than sympathomimetic toxicity in this patient? (Select all that apply)

Select all that apply

Dry, erythematous skin with completely absent axillary and facial sweat

Hypoactive or completely absent bowel sounds on abdominal auscultation

Markedly dilated pupils that are poorly responsive to direct light

Sustained ankle clonus and generalized hyperreflexia

Excessive oral secretions and diffuse pulmonary wheezing

Show answer & explanation

Answer: Dry, erythematous skin with completely absent axillary and facial sweat; Hypoactive or completely absent bowel sounds on abdominal auscultation

Answer

The correct physical examination findings that establish an anticholinergic toxidrome over a sympathomimetic toxidrome are dry, erythematous skin with completely absent sweat, and hypoactive or completely absent bowel sounds.

The patient presents with a hyper-adrenergic state characterized by tachycardia, hypertension, hyperthermia, and delirium. The key to differentiating an anticholinergic toxidrome from a sympathomimetic toxidrome lies in the muscarinic blockade specific to anticholinergics. Muscarinic receptors control eccrine sweat glands and gastrointestinal peristalsis. Therefore, anticholinergic toxicity classically presents with completely dry, hot, and flushed skin ('dry as a bone', 'red as a beet') and hypoactive or absent bowel sounds. In contrast, sympathomimetic agents typically cause profound diaphoresis (sweating) due to widespread sympathetic activation and leave bowel sounds normal or hyperactive.

Step-by-Step Solution

Analyze the patient's vital signs and mental status.

The patient exhibits hyperthermia, tachycardia, hypertension, and delirium/agitation.

These findings represent a hyper-adrenergic state, narrowing the primary differential to an anticholinergic or sympathomimetic toxidrome.

Evaluate the clinical overlap between the suspected toxidromes.

Both anticholinergic (e.g., diphenhydramine) and sympathomimetic (e.g., cocaine) ingestions cause elevated vitals, agitation, and mydriasis (dilated pupils).

Recognizing shared physical findings prevents premature closure and forces the clinician to look for distinguishing features.

Identify the physical examination findings unique to each toxidrome.

Anticholinergics inhibit sweat glands (anhidrosis) and gastrointestinal motility (hypoactive bowel sounds). Sympathomimetics stimulate sweat glands (diaphoresis) and do not significantly suppress bowel sounds.

Assessing skin moisture and abdominal bowel sounds provides the most reliable clinical differentiation between the two conditions.

Key Concept

While both anticholinergic and sympathomimetic toxidromes present with tachycardia, hypertension, hyperthermia, agitation, and mydriasis, they can be differentiated on physical examination by assessing skin moisture (anhidrosis in anticholinergic vs. diaphoresis in sympathomimetic) and gastrointestinal motility (decreased in anticholinergic vs. normal/increased in sympathomimetic).

Estimated Time:1m 15s

Question 1484Question →

A $38$ -year-old male is evaluated in the ambulatory clinic for newly discovered hypertension. During a health screening two weeks ago, his blood pressure was recorded at $162/100$ mmHg. Today, his vitals show a blood pressure of $158/98$ mmHg with a regular pulse of $76$ /min. The patient takes no daily medications and has no family history of early-onset cardiovascular disease. He mentions experiencing intermittent muscle cramps and generalized weakness over the past few months. Physical examination is unremarkable, with no abdominal bruits, abnormal facies, or purple striae. Initial basic metabolic panel results demonstrate a serum sodium of $144$ mEq/L and a serum potassium of $2.9$ mEq/L. Which of the following is the most appropriate next step in laboratory evaluation?

Intravenous saline suppression test

Measurement of plasma aldosterone concentration and plasma renin activity

Computed tomography of the adrenal glands

Adrenal venous sampling

24-hour urine collection for fractionated metanephrines

Show answer & explanation

Answer: Measurement of plasma aldosterone concentration and plasma renin activity

Answer

Measurement of plasma aldosterone concentration and plasma renin activity

The correct next step is the measurement of plasma aldosterone concentration (PAC) and plasma renin activity (PRA). This patient's presentation of newly discovered hypertension accompanied by spontaneous hypokalemia and muscle cramps is highly suspicious for primary hyperaldosteronism. The diagnostic algorithm for primary hyperaldosteronism requires strict sequencing. The very first step is biochemical screening utilizing the PAC/PRA ratio. In primary hyperaldosteronism, autonomous aldosterone secretion suppresses renin production, resulting in a significantly elevated ratio.

Step-by-Step Solution

Analyze the patient's clinical presentation and laboratory findings.

The patient has elevated blood pressure (

158/98

mmHg) paired with spontaneous, severe hypokalemia (

2.9

mEq/L) and muscle cramps.

Identifying the classic pairing of hypertension and unprovoked hypokalemia narrows the differential diagnosis significantly toward primary hyperaldosteronism (Conn syndrome).

Determine the appropriate diagnostic algorithm for the suspected condition.

The evaluation for primary hyperaldosteronism must follow a strict three-step sequence: 1) Initial biochemical screening, 2) Confirmatory testing, and 3) Subtype localization.

Skipping steps in the algorithm risks false-positive diagnoses or the discovery of non-functioning adrenal incidentalomas.

Identify the first step (screening test) in the diagnostic sequence.

The ratio of plasma aldosterone concentration (PAC) to plasma renin activity (PRA) is required.

An elevated PAC/PRA ratio (typically

>20

) with a high absolute PAC indicates autonomous aldosterone production independent of renin, prompting further confirmatory testing.

Key Concept

The diagnostic workup for primary hyperaldosteronism begins with screening via the plasma aldosterone concentration to plasma renin activity ratio, followed by confirmatory suppression testing, and finally localization imaging.

Question 1485Question →

A 28-year-old man is brought to the emergency department due to a 2-hour history of progressive swelling of his face, lips, and tongue, along with severe, crampy abdominal pain and nausea. He denies any recent changes in diet, insect stings, or new environmental exposures. He has no itching or skin rash. His temperature is 37.1 C (98.8 F), blood pressure is 110/70 mm Hg, pulse is 92/min, and respirations are 18/min. Physical examination shows pronounced, nonpitting edema of the lips and tongue, but no urticaria. Bowel sounds are hyperactive. The patient states that a similar, milder episode occurred when he was 15 years old following a tooth extraction. He takes no daily medications and has no known allergies. Initial treatment with intramuscular epinephrine, intravenous diphenhydramine, and corticosteroids is administered, but his condition remains unchanged 45 minutes later. Laboratory studies reveal a significantly decreased serum C4 level and a normal C3 level. Which of the following is the most likely primary mechanism mediating this patient's current symptoms?

Unregulated cleavage of high-molecular-weight kininogen

Cross-linking of surface IgE on tissue mast cells

Decreased enzymatic degradation of endogenous bradykinin

Deposition of circulating immune complexes and classical complement activation

Autoantibody-mediated consumption of C1q and C1 inhibitor

Show answer & explanation

Answer: Unregulated cleavage of high-molecular-weight kininogen

Answer

Unregulated cleavage of high-molecular-weight kininogen

This patient's presentation of recurrent, nonpitting edema without urticaria, accompanied by crampy abdominal pain, lack of response to epinephrine, and a low C4 level is highly characteristic of hereditary angioedema (HAE). HAE is an autosomal dominant disorder caused by a deficiency or dysfunction of C1 inhibitor (C1-INH). C1-INH is a serine protease inhibitor that normally inactivates C1r and C1s in the classical complement pathway, as well as kallikrein and coagulation factor XIIa in the contact activation pathway. In the absence of functional C1-INH, kallikrein becomes unregulated and excessively cleaves high-molecular-weight kininogen to produce bradykinin. Bradykinin is a potent vasodilator that increases vascular permeability, leading to the characteristic angioedema. Because the reaction is driven by bradykinin rather than histamine, it does not respond to standard anaphylaxis treatments (epinephrine, antihistamines, corticosteroids) and is not associated with urticaria. The unregulated C1s also continuously cleaves C4, making a low C4 level an excellent screening test for HAE.

Step-by-Step Solution

Analyze the clinical presentation and medication history.

The patient has isolated angioedema without urticaria or pruritus, and gastrointestinal involvement (abdominal pain), without taking any medications.

This helps rule out histamine-mediated allergic reactions (which typically feature urticaria) and medication-induced angioedema (e.g., ACE inhibitors).

Evaluate the response to initial therapy and laboratory findings.

The condition did not improve with epinephrine, antihistamines, or corticosteroids. Labs show low C4 and normal C3.

Lack of response to epinephrine confirms the edema is not histamine-mediated. A low C4 with normal C3 is the hallmark screening finding for C1 inhibitor deficiency.

Identify the underlying immunopathologic mechanism.

The patient has hereditary angioedema (HAE) due to C1 inhibitor deficiency. C1 inhibitor normally downregulates kallikrein. Its absence leads to uninhibited kallikrein, which cleaves high-molecular-weight kininogen into bradykinin.

Connecting the diagnosis to the molecular mechanism answers the question.

Key Concept

Hereditary angioedema is caused by C1 inhibitor deficiency, leading to unregulated kallikrein activation and excessive production of bradykinin from high-molecular-weight kininogen. It presents with angioedema without urticaria and a low C4 level.

Question 1486Question →

An infectious disease specialist is consulting on a 48-year-old male inpatient with a severe systemic infection. The patient's body mass is $75 \text{ kg}$ . The physician decides to start a continuous intravenous infusion of a narrow-therapeutic-index antibiotic. The established target steady-state serum concentration is $15 \text{ mg/L}$ . Pharmacokinetic data for this drug indicate a volume of distribution of $0.8 \text{ L/kg}$ and an elimination half-life of $13.86 \text{ hours}$ . Assuming first-order elimination kinetics, what maintenance infusion rate (in $\text{mg/hr}$ ) is required to sustain the target concentration?

Show answer & explanation

Answer: 45

Answer

The required maintenance infusion rate is

45 \text{ mg/hr}

For a continuous intravenous infusion, the amount of drug entering the body must perfectly match the amount of drug being eliminated in order to maintain a specific steady-state concentration (

C_{ss}

). The elimination rate of a drug is defined by its clearance (

CL

). Thus, the Maintenance Infusion Rate is calculated as

CL \times C_{ss}

. To find

CL

, both the elimination rate constant (

k_e

) and the absolute volume of distribution (

V_d

) are required.

V_d

is calculated by multiplying the given

0.8 \text{ L/kg}

by the patient's

75 \text{ kg}

body weight, yielding

60 \text{ L}

. The constant

k_e

is derived from the half-life (

t_{1/2}

) using the formula

k_e = \frac{0.693}{t_{1/2}}

, giving

0.05 \text{ hr}^{-1}

. Consequently,

CL = V_d \times k_e = 60 \text{ L} \times 0.05 \text{ hr}^{-1} = 3.0 \text{ L/hr}

. Multiplying this clearance by the target

C_{ss}

15 \text{ mg/L}

provides the correct maintenance infusion rate of

45 \text{ mg/hr}

Step-by-Step Solution

Calculate the total volume of distribution (

V_d

) for the patient.

V_d = 60 \text{ L}

The weight-based parameter (

0.8 \text{ L/kg}

) must be multiplied by the patient's total body weight (

75 \text{ kg}

) to find the absolute volume of distribution.

Calculate the elimination rate constant (

k_e

k_e = 0.05 \text{ hr}^{-1}

The elimination rate constant is inversely proportional to the half-life, calculated using the standard formula

k_e = \frac{0.693}{t_{1/2}}

Calculate the drug clearance (

CL

CL = 3.0 \text{ L/hr}

Clearance represents the volume of plasma entirely cleared of the drug per unit time, which is the product of

V_d

and

k_e

(

CL = V_d \times k_e

Calculate the maintenance infusion rate.

45 \text{ mg/hr}

To maintain a steady-state, the rate of drug administration must equal the rate of elimination. Therefore, Infusion Rate = Clearance

\times

Target Steady-State Concentration (

C_{ss}

Key Concept

Calculation of continuous infusion maintenance dosing using clearance and steady-state concentration goals.

Question 1487Question →

A 42-year-old woman is evaluated in the outpatient clinic for a 6-month history of progressive weight gain, easy bruising, and proximal muscle weakness. Physical examination reveals central adiposity, facial plethora, wide purple striae on her abdomen, and trace lower extremity edema. Her blood pressure is 155/95 mmHg. She takes no medications and denies the use of exogenous glucocorticoids or over-the-counter supplements. The physician suspects an endogenous endocrine disorder and plans a comprehensive diagnostic workup.

Arrange the following diagnostic laboratory tests and procedures in the most appropriate sequential order to establish the definitive diagnosis and etiology for this patient, starting with the initial diagnostic screening step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Measurement of 24-hour urine free cortisol or late-night salivary cortisol, 2) Measurement of morning plasma ACTH concentration, 3) Administration of a high-dose dexamethasone suppression test, and 4) Performance of inferior petrosal sinus sampling (IPSS).

The diagnostic algorithm for Cushing syndrome is inherently sequential to minimize false positives, reduce unnecessary invasive testing, and accurately localize the pathology. It begins by establishing the diagnosis with a screening test (e.g., 24-hour urine free cortisol). Next, ACTH is measured to distinguish between adrenal (ACTH-independent) and pituitary/ectopic (ACTH-dependent) etiologies. If ACTH-dependent, a high-dose dexamethasone suppression test evaluates the source, as pituitary adenomas typically retain some negative feedback response, whereas ectopic tumors do not. Finally, inferior petrosal sinus sampling is reserved as an invasive, definitive localizing step if non-invasive tests and imaging are equivocal.

Step-by-Step Solution

Confirm the presence of hypercortisolism.

Measurement of 24-hour urine free cortisol or late-night salivary cortisol.

The first step in evaluating suspected endogenous Cushing syndrome is to biochemically establish that the patient has pathological hypercortisolism, ruling out normal physiological variations.

Determine the ACTH dependence of the hypercortisolism.

Measurement of morning plasma ACTH concentration.

Once hypercortisolism is confirmed, ACTH levels differentiate between adrenal causes (low ACTH due to negative feedback) and ACTH-dependent causes (normal or elevated ACTH).

Differentiate the source of ACTH secretion.

Administration of a high-dose dexamethasone suppression test.

In ACTH-dependent hypercortisolism, a high-dose dexamethasone test helps distinguish a pituitary adenoma (which typically suppresses) from ectopic ACTH secretion (which typically does not suppress).

Definitively localize the ACTH source if non-invasive workup is indeterminate.

Performance of inferior petrosal sinus sampling (IPSS).

If biochemical tests and imaging are conflicting, IPSS is the gold standard invasive test to confirm a pituitary source of ACTH before proceeding to neurosurgery.

Key Concept

The diagnostic evaluation of Cushing syndrome follows a strict sequence: confirm hypercortisolism, establish ACTH dependence, and then localize the anatomical source.

Question 1488Question →

A 35-year-old man comes to the emergency department due to a 24-hour history of high fever, severe headache, photophobia, and nausea. Two months ago, he was evaluated for severe fatigue, episodic dark morning urine, and a recent hepatic vein thrombosis. At that time, flow cytometry of his peripheral blood demonstrated an absence of glycosylphosphatidylinositol (GPI)-anchored proteins, specifically CD55 and CD59, on the surface of his erythrocytes. He was subsequently started on a targeted monoclonal antibody therapy. Today, his temperature is $39.4^\circ\text{C}$ ( $102.9^\circ\text{F}$ ), blood pressure is $90/60\text{ mm Hg}$ , and pulse is $122/\text{min}$ . Physical examination reveals marked nuchal rigidity and a purpuric rash on the lower extremities. Cerebrospinal fluid analysis reveals a markedly elevated leukocyte count with a neutrophilic predominance, and Gram stain demonstrates intracellular Gram-negative diplococci. Which of the following best describes the immunologic mechanism of the patient's pharmacotherapy that directly led to his current presentation?

Blockade of C5 cleavage, preventing the assembly of the terminal membrane attack complex

Widespread consumption of early classical complement proteins, impairing bacterial opsonization

Depletion of CD20-positive B-lymphocytes, resulting in a profound secondary hypogammaglobulinemia

Disruption of alpha-4 integrin-mediated leukocyte transmigration across the blood-brain barrier

Inhibition of hepatic cytochrome P450 enzymes, causing rapid clearance of prophylactic antibiotics

Show answer & explanation

Answer: Blockade of C5 cleavage, preventing the assembly of the terminal membrane attack complex

Answer

The pharmacotherapy blocks C5 cleavage, which prevents the assembly of the terminal membrane attack complex.

The correct answer accurately describes the mechanism of eculizumab, the standard biologic therapy for Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is caused by an acquired mutation in the PIGA gene, leading to the absence of GPI-anchored proteins (CD55/decay-accelerating factor and CD59/MAC-inhibitory protein) that normally protect red blood cells from complement-mediated lysis. Eculizumab is a monoclonal antibody that binds to C5, preventing its cleavage into C5a and C5b. While this successfully halts the intravascular hemolysis by preventing the formation of the terminal membrane attack complex (MAC, C5b-9) on erythrocytes, it simultaneously creates a severe, acquired terminal complement deficiency. The MAC is immunologically essential for the lysis of thickly encapsulated bacteria, almost exclusively Neisseria species (e.g., N. meningitidis, N. gonorrhoeae). Consequently, patients on eculizumab are at a markedly increased risk of fulminant meningococcal meningitis and sepsis, requiring targeted vaccination prior to initiating therapy.

Step-by-Step Solution

Diagnose the patient's underlying condition based on the historical presentation.

The patient has Paroxysmal Nocturnal Hemoglobinuria (PNH).

The triad of hemolytic anemia (dark morning urine), pancytopenia/fatigue, and venous thrombosis (hepatic vein/Budd-Chiari syndrome) coupled with absent CD55/CD59 on flow cytometry is pathognomonic for PNH.

Identify the standard targeted pharmacotherapy for PNH.

Eculizumab is the indicated monoclonal antibody.

Eculizumab is a first-line biologic therapy that reduces hemolysis and the risk of thrombosis in patients with symptomatic PNH.

Determine the precise immunologic mechanism of this drug and its associated risks.

Eculizumab binds to C5, preventing its cleavage into C5a and C5b. This directly inhibits the formation of the membrane attack complex (MAC).

By blocking the terminal complement cascade, the drug prevents MAC-mediated destruction of the patient's red blood cells. However, because the MAC is critical for defense against encapsulated Neisseria species, patients are at extreme risk for severe meningococcal meningitis and sepsis.

Correlate the mechanism with the acute clinical presentation.

The patient's current presentation of meningitis with Gram-negative diplococci (Neisseria meningitidis) is a direct consequence of C5 blockade.

The inability to form the MAC due to C5 inhibition leaves the patient uniquely vulnerable to this specific pathogen.

Key Concept

Patients receiving terminal complement inhibitors (e.g., eculizumab) for Paroxysmal Nocturnal Hemoglobinuria are uniquely susceptible to invasive Neisseria meningitidis infections due to the inability to form the membrane attack complex (MAC).

Estimated Time:1m 30s

Question 1489Question →

An internal medicine physician is called to evaluate a 68-year-old hospitalized patient for new-onset confusion. The patient was admitted two days prior for community-acquired pneumonia and is currently receiving intravenous ceftriaxone and azithromycin. Vital signs remain within normal limits. On physical examination, mucous membranes are moist, skin turgor is normal, and there is no jugular venous distention or peripheral edema. A routine morning basic metabolic panel reveals a serum sodium concentration of $121 \text{ mEq/L}$ , a significant decrease from his admission baseline of $134 \text{ mEq/L}$ . Arrange the following laboratory tests in the most appropriate sequential order to systematically determine the underlying etiology of this patient's hyponatremia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence is: 1) Serum osmolality, 2) Urine osmolality, 3) Urine sodium concentration, 4) Serum TSH and morning cortisol levels.

The diagnostic algorithm for hyponatremia follows a strict physiological sequence. First, serum osmolality confirms that the patient actually has a hypotonic state rather than pseudohyponatremia. Second, urine osmolality determines if antidiuretic hormone (ADH) is present; if

> 100 \text{ mOsm/kg}

, water excretion is impaired. Third, urine sodium assesses the effective arterial blood volume to classify the hyponatremia as hypovolemic, euvolemic, or hypervolemic. Finally, if the patient is euvolemic, secondary endocrine causes like hypothyroidism or adrenal insufficiency must be ruled out with TSH and cortisol testing before a diagnosis of SIADH (which is a diagnosis of exclusion) can be firmly established.

Step-by-Step Solution

Determine if the hyponatremia is truly hypotonic by ordering serum osmolality.

Hypotonic hyponatremia is confirmed if serum osmolality is low (typically

< 275 \text{ mOsm/kg}

This rules out hypertonic hyponatremia (e.g., from severe hyperglycemia) and isotonic pseudohyponatremia (e.g., from severe hyperlipidemia or hyperproteinemia).

Assess the renal response to hypotonicity by ordering urine osmolality.

Impaired free water excretion is confirmed if urine osmolality is inappropriately concentrated (typically

> 100 \text{ mOsm/kg}

This differentiates conditions of appropriate antidiuretic hormone (ADH) suppression (like primary polydipsia) from states with active ADH secretion.

Evaluate effective arterial blood volume by ordering urine sodium concentration.

In a clinically euvolemic patient, a urine sodium

> 40 \text{ mEq/L}

supports euvolemic hyponatremia (such as SIADH).

Urine sodium helps differentiate between hypovolemic hyponatremia (where kidneys retain sodium, resulting in urine Na

< 20 \text{ mEq/L}

) and euvolemic/hypervolemic states.

Rule out endocrine mimicking conditions by ordering serum TSH and morning cortisol.

Normal TSH and cortisol levels confirm the diagnosis of Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

Severe hypothyroidism and glucocorticoid deficiency can cause euvolemic hyponatremia and must be excluded before formally diagnosing SIADH.

Key Concept

Sequential laboratory evaluation of hyponatremia

Estimated Time:1m 30s

Question 1490Question →

A young adult male is brought to the emergency department following an off-road motorcycle collision that resulted in a highly contaminated open fracture of the right tibia. He undergoes prompt surgical debridement and receives tetanus prophylaxis along with empiric broad-spectrum antibiotics. Approximately 36 hours post-operation, he develops excruciating pain at the surgical site that is out of proportion to the visible signs of inflammation. Examination of the leg reveals marked edema, a bronze-colored cutaneous discoloration, and palpable crepitus in the surrounding tissues. Gram stain of a serosanguineous exudate from the wound demonstrates large Gram-positive bacilli with blunt ends and a notable absence of polymorphonuclear leukocytes. Which of the following best describes the molecular mechanism of the primary virulence factor responsible for this patient's rapidly progressive tissue destruction?

Degradation of cellular membrane phospholipids resulting in widespread cytolysis

ADP-ribosylation of elongation factor 2 leading to the cessation of protein synthesis

Proteolytic cleavage of SNARE proteins resulting in blockade of neurotransmitter release

Enzymatic glycosylation of Rho-family GTPases causing actin cytoskeletal disruption

Widespread cross-linking of T-cell receptors to major histocompatibility complex class II molecules

Show answer & explanation

Answer: Degradation of cellular membrane phospholipids resulting in widespread cytolysis

Answer

The correct answer is the degradation of cellular membrane phospholipids resulting in widespread cytolysis.

The clinical presentation of a severe, rapidly progressive soft tissue infection with crepitus, bronze skin discoloration, and pain out of proportion to physical findings following a highly contaminated trauma is classic for clostridial myonecrosis, or gas gangrene. The Gram stain showing large, blunt-ended Gram-positive bacilli with a notable absence of polymorphonuclear leukocytes strongly points to Clostridium perfringens. The absence of leukocytes in the exudate is highly characteristic and is due to the organism's robust production of alpha toxin. Alpha toxin is a lecithinase (a type of phospholipase C) that enzymatically degrades the phospholipid bilayer of host cell membranes. This leads directly to the lysis of erythrocytes, leukocytes, and muscle cells, facilitating rapid, widespread tissue destruction and creating a highly anaerobic environment that promotes further bacterial replication.

Step-by-Step Solution

Identify the clinical syndrome and the most likely responsible pathogen based on the presentation.

The patient has gas gangrene (clostridial myonecrosis) caused by Clostridium perfringens.

The contaminated traumatic wound, rapid onset of pain out of proportion to exam, bronze skin discoloration, crepitus (tissue gas), and a Gram stain showing large Gram-positive bacilli without neutrophils are classic diagnostic markers.

Determine the primary virulence factor associated with this specific pathogen.

The primary virulence factor for Clostridium perfringens is alpha toxin (a lecithinase).

Alpha toxin is directly responsible for the massive tissue necrosis, hemolysis, and systemic toxicity characteristic of this severe infection.

Identify the exact molecular mechanism of this virulence factor.

Alpha toxin functions as a phospholipase C.

It hydrolyzes lecithin in host cell membranes, leading to the destruction of the phospholipid bilayer, causing lysis of erythrocytes, leukocytes (explaining their absence on Gram stain), and muscle cells.

Key Concept

The pathogenesis of clostridial myonecrosis (gas gangrene) relies on Clostridium perfringens alpha toxin, a lecithinase (phospholipase C) that degrades cellular membrane phospholipids, leading to widespread cell lysis and tissue necrosis.

Question 1491Question →

A $56$ -year-old woman presents to the clinic with a $7$ -month history of progressive fatigue, episodic facial flushing, and chronic watery diarrhea. She also reports bilateral leg swelling that has worsened over the past few weeks. Her medical history is unremarkable, and she takes no medications. Vital signs show a temperature of $37.1^{\circ}\text{C}$ ( $98.8^{\circ}\text{F}$ ), pulse of $92\text{/min}$ , blood pressure of $115/70\text{ mmHg}$ , and respirations of $16\text{/min}$ . On physical examination, blanching telangiectasias are noted on her face and neck. Jugular venous distention is present. The abdomen is soft, but a firm, irregular liver edge is palpated $5\text{ cm}$ below the right costal margin. Cardiac auscultation reveals a prominent right ventricular heave and a grade $3/6$ holosystolic murmur best heard at the left lower sternal border. Which of the following dynamic physical examination findings is most likely to be present in this patient?

The holosystolic murmur becomes louder during sustained isometric handgrip.

Intermittent giant "a" waves are visualized in the jugular venous pulsation.

The intensity of the holosystolic murmur increases during deep inspiration.

Systolic blood pressure decreases by

> 10\text{ mmHg}

during normal inspiration.

A high-pitched, blowing, early diastolic murmur is appreciated at the right upper sternal border.

Show answer & explanation

Answer: The intensity of the holosystolic murmur increases during deep inspiration.

Answer

The intensity of the holosystolic murmur increases during deep inspiration.

The patient's clinical presentation of episodic facial flushing, chronic watery diarrhea, and hepatomegaly (metastatic liver disease) is highly characteristic of carcinoid syndrome. Carcinoid tumors secrete vasoactive substances, primarily serotonin. When these tumors metastasize to the liver, the hormones bypass hepatic metabolism and enter the systemic venous circulation, reaching the right side of the heart. This leads to endocardial fibrosis, characteristically causing tricuspid regurgitation and pulmonic stenosis. The left side of the heart is typically spared because serotonin is inactivated by monoamine oxidase in the pulmonary vascular bed. The patient's holosystolic murmur at the left lower sternal border is classic for tricuspid regurgitation. Dynamic auscultation of right-sided murmurs reveals an increase in intensity with deep inspiration (Carvallo's sign). Inspiration creates negative intrathoracic pressure, which increases venous return to the right heart, thereby increasing the right ventricular stroke volume and the regurgitant flow across the incompetent tricuspid valve.

Step-by-Step Solution

Synthesize the clinical presentation.

The combination of episodic facial flushing, chronic watery diarrhea, telangiectasias, and hepatomegaly strongly suggests carcinoid syndrome with liver metastases.

Identifying the underlying systemic neuroendocrine disease is required to understand the etiology of the cardiac findings.

Identify the cardiac pathology.

Metastatic carcinoid tumors release serotonin into the systemic venous circulation, causing endocardial fibrosis of the right heart and leading to tricuspid regurgitation.

Right-sided heart valves are selectively affected because vasoactive amines like serotonin are inactivated by monoamine oxidase in the lungs, sparing the left heart.

Determine the dynamic physical exam finding for tricuspid regurgitation.

Tricuspid regurgitation presents as a holosystolic murmur at the left lower sternal border that increases in intensity with deep inspiration.

Inspiration decreases intrathoracic pressure, increasing venous return to the right heart and thus increasing the right-sided regurgitant volume (Carvallo's sign).

Key Concept

Carcinoid heart disease typically causes right-sided valvular lesions, most commonly tricuspid regurgitation, the murmur of which characteristically increases in intensity with deep inspiration (Carvallo's sign).

Estimated Time:1m 30s

Question 1492Question →

A 54-year-old male construction worker visits his primary care provider complaining of a 6-month history of progressive fatigue, generalized weakness, and joint pain affecting his hands, wrists, and knees. He also mentions a recent, uncharacteristic decline in libido. His medical history is notable for type 2 diabetes mellitus diagnosed one year ago, which is currently managed with metformin. Vital signs are within normal limits. Physical examination reveals a firm, palpable liver edge 4 cm below the right costal margin and a diffuse, bronze-colored hyperpigmentation of the skin that is most prominent on his face and forearms. Joint examination demonstrates bony enlargement of the second and third metacarpophalangeal joints bilaterally without significant warmth, erythema, or synovial thickening. Which of the following is the most appropriate next step in laboratory evaluation?

Genetic testing for HFE gene mutations

Rheumatoid factor and anti-cyclic citrullinated peptide antibodies

Serum transferrin saturation and ferritin levels

Early morning total and free serum testosterone

Magnetic resonance imaging of the abdomen

Show answer & explanation

Answer: Serum transferrin saturation and ferritin levels

Answer

Serum transferrin saturation and ferritin levels

This patient presents with a classic constellation of symptoms for hereditary hemochromatosis (HH), including new-onset atypical diabetes mellitus, hepatomegaly, bronze-colored skin hyperpigmentation, hypogonadism (evidenced by decreased libido), and a characteristic arthropathy involving the second and third metacarpophalangeal (MCP) joints. The most appropriate initial step in the laboratory evaluation of suspected HH is obtaining a serum transferrin saturation and a serum ferritin level. A transferrin saturation greater than 45% is highly sensitive for HH and warrants further confirmatory testing.

Step-by-Step Solution

Identify the underlying clinical syndrome based on the patient's comprehensive presentation.

The patient exhibits new-onset diabetes, hepatomegaly, bronze skin hyperpigmentation, specific arthropathy (2nd and 3rd MCP joints), and hypogonadism.

This constellation of findings is the classic presentation for hereditary hemochromatosis, a disorder of systemic iron overload.

Determine the most appropriate initial diagnostic laboratory test for the suspected condition.

The initial screening test is an iron panel, specifically serum transferrin saturation and ferritin levels.

Non-invasive, cost-effective biochemical evidence of iron overload (transferrin saturation > 45%) is required before proceeding to confirmatory genetic testing or invasive biopsies.

Key Concept

The most appropriate initial laboratory evaluation for patients presenting with clinical signs of hereditary hemochromatosis (e.g., hepatomegaly, skin hyperpigmentation, new-onset diabetes, and MCP arthropathy) is measuring serum transferrin saturation and ferritin levels.

Question 1493Question →

A 45-year-old man is hospitalized for the treatment of relapsed diffuse large B-cell lymphoma. Three days ago, he received an infusion of anti-CD19 chimeric antigen receptor (CAR) T cells. He now acutely develops a temperature of 39.8°C (103.6°F), a heart rate of 125/min, and blood pressure of 82/45 mm Hg that is unresponsive to a 2-liter intravenous fluid bolus. Oxygen saturation is 93% on room air. Laboratory evaluation reveals profoundly elevated serum ferritin, C-reactive protein, and lactate dehydrogenase. The patient is diagnosed with a severe immunologic complication related to his recent cellular therapy. Which of the following is the most appropriate targeted intervention for this patient's current condition?

Administration of a monoclonal antibody that blocks the interleukin-6 receptor

Administration of a monoclonal antibody that directly neutralizes tumor necrosis factor-alpha

Administration of a monoclonal antibody targeting CD52 to deplete circulating lymphocytes

Immediate performance of a bone marrow aspiration and biopsy

Administration of a cytochrome P450 3A4 inhibitor to prolong the circulating half-life of the therapy

Show answer & explanation

Answer: Administration of a monoclonal antibody that blocks the interleukin-6 receptor

Answer

Administration of a monoclonal antibody that blocks the interleukin-6 receptor

This patient is experiencing severe Cytokine Release Syndrome (CRS), a life-threatening complication of chimeric antigen receptor (CAR) T-cell therapy. The profound activation of engineered CAR-T cells interacting with tumor antigens leads to downstream activation of bystander immune cells, particularly macrophages. This massive immune activation results in the release of large quantities of pro-inflammatory cytokines, with interleukin-6 (IL-6) being the primary driver of the systemic response. The clinical presentation classically includes high fever, distributive shock, and markedly elevated acute phase reactants such as ferritin and C-reactive protein. The most appropriate targeted therapy for hemodynamically unstable CRS is an IL-6 receptor antagonist, such as tocilizumab, often combined with systemic corticosteroids.

Step-by-Step Solution

Analyze the patient's clinical presentation and recent therapeutic history.

The patient presents with high fever, refractory distributive shock, and markedly elevated inflammatory markers (ferritin, CRP) three days after receiving CAR-T cell therapy.

Establishing the clinical diagnosis of Cytokine Release Syndrome (CRS) is the required first step before selecting a targeted therapy.

Identify the primary immunopathologic mechanism driving the clinical condition.

Severe CRS is driven by massive systemic immune activation, predominantly mediated by extreme elevations of the cytokine interleukin-6 (IL-6) secreted by macrophages.

Understanding the primary cytokine mediator is necessary to select the most precise targeted pharmacotherapy.

Select the specific targeted immunologic intervention.

An IL-6 receptor antagonist (such as tocilizumab) is the standard of care for severe, hemodynamically unstable CRS.

This agent directly neutralizes the pathophysiologic driver of the cytokine storm without destroying the therapeutic CAR-T cells.

Key Concept

Cytokine Release Syndrome (CRS) following CAR-T cell therapy is a systemic inflammatory response primarily mediated by interleukin-6 (IL-6) and is managed acutely with targeted IL-6 receptor antagonists.

Estimated Time:1m 30s

Question 1494Question →

A 27-year-old man establishes care for evaluation of resting tachycardia and occasional palpitations. He feels otherwise well and has no weight changes, heat intolerance, or visual disturbances. His pulse is 108/min and blood pressure is 138/82 mmHg. Physical examination reveals a normal-sized, non-tender thyroid gland and a fine resting tremor. There is no proptosis or pretibial myxedema. Laboratory studies show:

Laboratory Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	4.5 mIU/L	0.5 - 5.0 mIU/L
Free Thyroxine (T4)	3.2 ng/dL	0.9 - 2.4 ng/dL
Free Triiodothyronine (T3)	5.8 pg/mL	2.3 - 4.2 pg/mL
TSH receptor antibodies	Undetectable	-

A recent magnetic resonance imaging (MRI) of the brain, ordered by his previous provider, showed a normal pituitary gland and sella turcica. Serum alpha-subunit levels are within normal limits. Which of the following describes the fundamental molecular mechanism underlying this patient's laboratory abnormalities?

Stimulatory autoantibody binding to a G-protein coupled transmembrane receptor

Autonomous hypersecretion of a heterodimeric glycoprotein by anterior pituitary cells

Impaired ligand binding to an intracellular nuclear transcription factor

Pharmacologic inhibition of peripheral 5'-deiodinase activity

Reduced hepatic synthesis of a hormone-transporting carrier protein

Show answer & explanation

Answer: Impaired ligand binding to an intracellular nuclear transcription factor

Answer

Impaired ligand binding to an intracellular nuclear transcription factor

The correct answer identifies impaired ligand binding to an intracellular nuclear transcription factor. This patient's laboratory profile shows elevated free T4 and free T3 with an inappropriately normal TSH, indicating a state of central resistance to thyroid hormone negative feedback. The normal pituitary MRI and normal alpha-subunit levels effectively rule out a TSH-secreting pituitary adenoma. This leaves Resistance to Thyroid Hormone (RTH), which is most commonly caused by an autosomal dominant mutation in the THRB gene. This gene encodes the thyroid hormone receptor beta (TR-beta), which functions physiologically as an intracellular nuclear transcription factor. The mutated receptor has decreased affinity for T3, preventing appropriate suppression of TSH in the anterior pituitary gland. Meanwhile, the unmutated TR-alpha receptors in the heart remain highly responsive to the elevated circulating levels of thyroid hormone, leading to the patient's presenting tachycardia.

Step-by-Step Solution

Interpret the thyroid function tests.

The patient has elevated free T4 and free T3 with an inappropriately normal TSH.

This specific pattern indicates a failure of normal negative feedback on the hypothalamic-pituitary-thyroid axis, effectively ruling out primary hyperthyroidism where TSH would be strongly suppressed.

Differentiate the causes of unsuppressed TSH with elevated thyroid hormones.

The primary differential diagnosis narrows down to a TSH-secreting pituitary adenoma and Resistance to Thyroid Hormone (RTH).

Both of these conditions present with central hyperthyroidism or resistance, causing normal or elevated TSH despite high circulating free thyroid hormones.

Incorporate additional diagnostic imaging and biomarker data.

The normal pituitary MRI and normal alpha-subunit levels effectively rule out a TSH-secreting pituitary adenoma.

TSH-omas typically present as visible macroadenomas on neuroimaging and frequently co-secrete the common alpha-subunit of glycoprotein hormones.

Identify the molecular mechanism of Resistance to Thyroid Hormone (RTH).

RTH is most commonly caused by a mutation in the thyroid hormone receptor beta (TR-beta) gene.

TR-beta functions as an intracellular nuclear transcription factor. The mutation leads to impaired ligand (T3) binding, causing defective negative feedback in the pituitary gland.

Key Concept

Resistance to thyroid hormone (RTH) presents with elevated free T4 and T3 alongside unsuppressed TSH due to defective negative feedback. It is most commonly caused by mutations in the intracellular nuclear thyroid hormone receptor beta (TR-beta).

Question 1495Question →

A 27-year-old woman is brought to the emergency department by her partner due to severe, diffuse abdominal pain and new-onset confusion that began 24 hours ago. The pain is severe, constant, and associated with nausea and non-bilious vomiting. Three days ago, she was evaluated at an urgent care center for a presumed urinary tract infection and was prescribed oral trimethoprim-sulfamethoxazole. She has no other medical history and does not use tobacco, alcohol, or illicit drugs.

Temperature is 37.1°C (98.8°F), blood pressure is 165/100 mmHg, pulse is 118/min, and respirations are 18/min. Physical examination shows an anxious and profusely diaphoretic woman. The abdomen is soft and non-distended with diffuse mild discomfort on deep palpation, but there is no localized tenderness, guarding, or rebound. Bowel sounds are diminished. Neurologic examination reveals symmetric 4/5 weakness in the proximal upper and lower extremities and decreased deep tendon reflexes.

Laboratory studies show:

Laboratory Test	Result	Reference Range
Hemoglobin	$13.8 \text{ g/dL}$	$12.0-16.0 \text{ g/dL}$
Leukocyte count	$8,500/\text{mm}^3$	$4,500-11,000/\text{mm}^3$
Platelet count	$210,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Sodium	$122 \text{ mEq/L}$	$136-145 \text{ mEq/L}$
Potassium	$3.9 \text{ mEq/L}$	$3.5-5.0 \text{ mEq/L}$
Bicarbonate	$24 \text{ mEq/L}$	$22-28 \text{ mEq/L}$
Blood urea nitrogen	$10 \text{ mg/dL}$	$8-20 \text{ mg/dL}$
Creatinine	$0.7 \text{ mg/dL}$	$0.6-1.2 \text{ mg/dL}$
Aspartate aminotransferase (AST)	$45 \text{ U/L}$	$8-40 \text{ U/L}$
Alanine aminotransferase (ALT)	$35 \text{ U/L}$	$7-35 \text{ U/L}$
Lipase	$35 \text{ U/L}$	$10-140 \text{ U/L}$

Serum $\beta$ -hCG is negative. A non-contrast CT scan of the head shows no abnormalities.

Which of the following is the most appropriate next step in laboratory evaluation?

Measurement of spot urine porphobilinogen

24-hour urine collection for fractionated porphyrins

CT angiography of the abdomen and pelvis

Measurement of whole blood lead level

Measurement of serum acetaminophen level

Show answer & explanation

Answer: Measurement of spot urine porphobilinogen

Answer

Measurement of spot urine porphobilinogen is the correct next step in laboratory evaluation.

The correct answer is measurement of spot urine porphobilinogen. This patient's clinical picture of severe abdominal pain with a benign abdominal examination, autonomic hyperactivity (tachycardia, severe hypertension, diaphoresis), profound hyponatremia, and new-onset proximal motor weakness is highly characteristic of an acute attack of acute intermittent porphyria (AIP). AIP is an autosomal dominant disorder of heme biosynthesis caused by a deficiency of the enzyme porphobilinogen deaminase. Acute neurovisceral attacks are classically precipitated by factors that upregulate hepatic cytochrome P450 enzymes—such as certain medications (e.g., sulfonamide antibiotics, antiepileptics), fasting, or alcohol use—leading to the toxic accumulation of porphyrin precursors. The hyponatremia is typically driven by the syndrome of inappropriate antidiuretic hormone secretion (SIADH) resulting from hypothalamic involvement. During an acute attack, the most appropriate, sensitive, and rapid initial laboratory test is a spot urine assay for porphobilinogen (PBG), which will be markedly elevated.

Step-by-Step Solution

Analyze the patient's clinical presentation.

The patient exhibits severe neurovisceral symptoms including abdominal pain without peritoneal signs, autonomic hyperactivity (tachycardia, hypertension, diaphoresis), confusion, and new-onset proximal motor weakness.

Identifying the constellation of neuropathic pain, autonomic instability, and motor deficits helps narrow the differential diagnosis to systemic or metabolic etiologies rather than primary intra-abdominal pathology.

Identify potential triggers and correlate with laboratory findings.

The symptoms began shortly after starting trimethoprim-sulfamethoxazole (a known cytochrome P450 inducer). Laboratory results reveal profound hyponatremia (

122 \text{ mEq/L}

Sulfonamides are classic precipitants of acute intermittent porphyria (AIP) attacks by increasing hepatic heme demand. The severe hyponatremia is consistent with the syndrome of inappropriate antidiuretic hormone secretion (SIADH), a well-known complication of acute porphyria.

Determine the most appropriate initial laboratory test.

The initial screening test of choice is the measurement of spot urine porphobilinogen (PBG).

During an acute attack of AIP, porphobilinogen deaminase deficiency leads to a rapid, massive accumulation of the upstream precursor PBG. A spot urine test is highly sensitive, rapidly obtainable, and minimally invasive for confirming the diagnosis in the emergency setting.

Key Concept

Diagnosis and acute evaluation of Acute Intermittent Porphyria (AIP)

Question 1496Question →

Match the following distinct neurological physical examination findings with the corresponding clinical condition or anatomic lesion.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Complete unilateral facial weakness matches peripheral CN VII lesion; ptosis, miosis, and anhidrosis match sympathetic pathway disruption; lower facial weakness with forehead sparing matches upper motor neuron facial lesion; and a down-and-out eye with a dilated pupil matches a compressive CN III lesion.

The correct pairings rely on precise neuroanatomic localization. The upper face receives bilateral cortical innervation, so a central lesion spares the forehead, while a peripheral lesion affects the whole half of the face. Horner syndrome results from sympathetic disruption, causing miosis and partial ptosis, whereas a compressive CN III lesion disrupts both somatic and superficial parasympathetic fibers, leading to a blown pupil and profound ptosis.

Step-by-Step Solution

Analyze each neurological physical finding to determine the specific affected muscles, pupils, or autonomic signs.

The findings correspond to a complete facial palsy, Horner syndrome, a central facial palsy, and a complete oculomotor nerve palsy.

Identifying the specific pattern of deficits is the foundation for localizing neurological lesions.

Recall the neuroanatomical pathways responsible for these clinical presentations.

Understanding the difference between bilateral versus unilateral cortical innervation explains the facial palsies, while sympathetic versus parasympathetic pathways explain the pupillary findings.

Precise anatomic localization allows the matching of physical signs to their underlying structural lesions.

Match the constellation of signs with the specific nerve or pathway lesion.

The correct anatomic lesions are paired with their classic physical examination presentations.

This confirms the diagnosis based strictly on the physical examination.

Key Concept

Neurological Physical Examination Findings

Question 1497Question →

Evaluate the following distinct patient encounters. For each clinical presentation, select the most appropriate targeted laboratory testing panel to establish the diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Primary syphilis matches with Treponemal/Non-treponemal testing; Dengue fever matches with NS1 antigen and IgM ELISA; Active pulmonary tuberculosis matches with Sputum AFB, culture, and NAAT; Infectious mononucleosis matches with Heterophile antibody and EBV VCA IgM.

Each pairing links a highly specific clinical vignette to the standard-of-care initial diagnostic laboratory evaluation required to establish the diagnosis, matching the syndrome to the correct microbiological or serological assay.

Step-by-Step Solution

Analyze the clinical features and epidemiologic risks of the 24-year-old male with a painless penile ulcer.

Identify primary syphilis as the most likely diagnosis.

A painless, indurated ulcer (chancre) and regional lymphadenopathy are highly specific for Treponema pallidum infection.

Select the appropriate laboratory test for primary syphilis.

Match with Treponemal-specific immunoassay and non-treponemal test.

Modern syphilis screening utilizes a reverse sequence algorithm (treponemal test first) or traditional algorithm, both requiring both test types for confirmation.

Analyze the 32-year-old female returning from Puerto Rico with retro-orbital pain and myalgias.

Identify dengue fever.

Travel to an endemic area combined with high fever, retro-orbital headache, and severe muscle pain characterizes dengue.

Select the appropriate laboratory test for acute dengue fever.

Match with Dengue virus NS1 antigen and IgM ELISA.

During the acute phase (days 1-7), the NS1 antigen is highly detectable, while IgM appears slightly later but confirms acute infection.

Evaluate the 45-year-old male with chronic cough, night sweats, and a cavitary lesion.

Identify pulmonary tuberculosis.

The chronicity of symptoms combined with classic radiographic findings (apical cavitation) points to Mycobacterium tuberculosis.

Determine the diagnostic workup for suspected active tuberculosis.

Match with Sputum AFB smear, mycobacterial culture, and NAAT.

Three sputum samples are required for smear and culture to isolate the organism and determine susceptibility, with NAAT providing rapid confirmation.

Assess the 19-year-old student with severe pharyngitis, posterior cervical adenopathy, and a negative strep test.

Identify infectious mononucleosis.

Posterior cervical lymphadenopathy and pronounced fatigue, especially in a young adult with a negative strep test, strongly indicate EBV infection.

Select the lab test for infectious mononucleosis.

Match with Heterophile antibody screening and EBV VCA IgM.

The heterophile antibody test is a rapid, specific screen for EBV in symptomatic patients, while EBV VCA IgM confirms acute infection if the monospot is negative.

Key Concept

Selection of targeted diagnostic laboratory panels based on specific clinical infectious disease presentations and epidemiological risk factors.

Question 1498Question →

A 48-year-old man presents to the transplant clinic with a 2-day history of decreased urine output, malaise, and mild right lower quadrant pain. He underwent a deceased-donor kidney transplantation 4 months ago for end-stage renal disease secondary to IgA nephropathy. His maintenance immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and low-dose prednisone. Vital signs show a temperature of 37.8°C (100°F) and blood pressure of 152/94 mm Hg. Physical examination reveals tenderness over the allograft in the right lower quadrant. Laboratory studies demonstrate a serum creatinine of 3.4 mg/dL, representing an acute increase from his baseline of 1.4 mg/dL obtained two weeks ago. Urinalysis shows 1+ protein and no white blood cells.

Arrange the following steps in the most appropriate chronological order for the evaluation and management of this patient's acute allograft dysfunction.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Perform renal allograft ultrasound with Doppler and obtain a serum tacrolimus trough level, 2) Perform a percutaneous renal allograft biopsy, 3) Initiate high-dose intravenous methylprednisolone therapy, 4) Administer intravenous anti-thymocyte globulin (ATG).

The evaluation of acute renal allograft dysfunction must proceed in a stepwise fashion to balance diagnostic accuracy with patient safety. The first step is to exclude pre-renal, post-renal (e.g., urinary obstruction, lymphocele), and vascular causes (e.g., renal artery thrombosis), as well as calcineurin inhibitor toxicity, using non-invasive methods like renal Doppler ultrasound and tacrolimus trough levels. Once these are excluded, a percutaneous allograft biopsy is required to establish a definitive histopathologic diagnosis. This differentiates acute cellular rejection (ACR) from antibody-mediated rejection or opportunistic infection (e.g., BK polyomavirus). After ACR is confirmed, high-dose intravenous corticosteroids (e.g., pulse methylprednisolone) are administered as first-line therapy. If the rejection proves refractory to corticosteroids, or if the initial biopsy demonstrates severe Grade III rejection with extensive vascular involvement, second-line therapy with a lymphocyte-depleting agent such as anti-thymocyte globulin (ATG) is indicated.

Step-by-Step Solution

Select the most appropriate initial non-invasive evaluation.

Perform renal allograft ultrasound with Doppler and obtain a tacrolimus trough level.

Before invasive procedures or potent immunosuppressants are utilized, mechanical complications (e.g., obstruction, thrombosis, lymphocele) and calcineurin inhibitor toxicity must be ruled out.

Determine the next diagnostic step after excluding structural/toxic causes.

Perform a percutaneous renal allograft biopsy.

A definitive tissue diagnosis is required to distinguish acute cellular rejection from antibody-mediated rejection or infectious causes (such as BK virus nephropathy), which have drastically different treatments.

Identify the first-line therapy once acute cellular rejection is confirmed.

Initiate high-dose intravenous methylprednisolone therapy.

Pulse corticosteroids are the initial treatment of choice for acute cellular rejection to rapidly suppress the T-cell mediated inflammatory response.

Select the appropriate therapy for cases that fail initial management.

Administer intravenous anti-thymocyte globulin (ATG).

If the rejection does not respond to corticosteroids, escalating therapy with a T-cell depleting agent is necessary to salvage the allograft.

Key Concept

The sequential management of acute renal allograft dysfunction involves initial non-invasive testing to rule out mechanical and toxic etiologies, followed by an allograft biopsy for definitive diagnosis, treatment with first-line pulse corticosteroids for cellular rejection, and escalation to lymphocyte-depleting agents for refractory cases.

Question 1499Question →

A 58-year-old man with type 2 diabetes mellitus and heart failure with reduced ejection fraction presents to the emergency department with nausea, diffuse abdominal pain, and profound fatigue for the past 24 hours. Two days ago, he underwent a colonoscopy, for which he completed a standard bowel preparation and fasted. His medications include metformin, lisinopril, carvedilol, and a medication that was added one month ago for his heart failure. On physical examination, his blood pressure is 105/65 mm Hg, pulse is 112/min, and respirations are 24/min and deep. Mucous membranes are dry.

Laboratory results:

Test	Result
Serum sodium	135 mEq/L
Serum potassium	4.8 mEq/L
Serum chloride	98 mEq/L
Serum bicarbonate	12 mEq/L
Blood urea nitrogen	32 mg/dL
Serum creatinine	1.5 mg/dL
Serum glucose	172 mg/dL
Arterial pH	7.24
Arterial pCO2	26 mm Hg
Urinalysis	3+ glucose, 4+ ketones

Which of the following best describes the primary biochemical mechanism responsible for this patient's acid-base disturbance?

Decreased malonyl-CoA production leading to disinhibition of hepatic carnitine palmitoyltransferase-I

Direct inhibition of hepatic mitochondrial glycerol-3-phosphate dehydrogenase

Absolute deficiency of endogenous insulin leading to unrestricted hormone-sensitive lipase activity

Accumulation of organic unmeasured anions secondary to an acute reduction in glomerular filtration rate

Cytosolic accumulation of NADH and pyruvate due to impaired peripheral tissue perfusion

Show answer & explanation

Answer: Decreased malonyl-CoA production leading to disinhibition of hepatic carnitine palmitoyltransferase-I

Answer

Decreased malonyl-CoA production leading to disinhibition of hepatic carnitine palmitoyltransferase-I

This patient's presentation of high anion gap metabolic acidosis, significant ketonuria, and a mildly elevated blood glucose level in the setting of a recent fasting state and a newly added heart failure medication is highly characteristic of euglycemic diabetic ketoacidosis (DKA) induced by a sodium-glucose cotransporter-2 (SGLT2) inhibitor. SGLT2 inhibitors promote renal glycosuria, which artificially lowers blood glucose. This relative carbohydrate deficit triggers a marked decrease in endogenous insulin secretion and an increase in glucagon secretion from the pancreas. In the liver, this low insulin-to-glucagon ratio inhibits the enzyme acetyl-CoA carboxylase, resulting in decreased production of malonyl-CoA. Malonyl-CoA is a potent allosteric inhibitor of carnitine palmitoyltransferase-I (CPT-I). Its reduction effectively disinhibits CPT-I, allowing large amounts of free fatty acids to be transported into the mitochondria for beta-oxidation. This leads to the massive overproduction of ketone bodies (acetoacetate and beta-hydroxybutyrate), generating the severe high anion gap metabolic acidosis.

Step-by-Step Solution

Calculate the anion gap and characterize the primary acid-base disturbance.

Anion gap =

135 - (98 + 12) = 25

. The pH is 7.24 with low bicarbonate and a compensatory decrease in pCO2, indicating a primary high anion gap metabolic acidosis.

Establishing the specific type of acid-base disorder narrows the differential diagnosis to etiologies such as ketoacidosis, lactic acidosis, uremia, or toxic ingestions.

Synthesize the laboratory findings with the clinical history to establish the exact diagnosis.

The patient has a high anion gap metabolic acidosis with 4+ ketonuria but a relatively normal blood glucose of 172 mg/dL. He recently started a new heart failure medication (likely an SGLT2 inhibitor) and underwent fasting.

These findings represent the classic triad of SGLT2 inhibitor-induced euglycemic diabetic ketoacidosis (DKA) triggered by fasting/dehydration.

Identify the cellular biochemical mechanism driving the ketogenesis.

SGLT2 inhibitors lower blood glucose, leading to decreased insulin and increased glucagon secretion. This low insulin-to-glucagon ratio suppresses acetyl-CoA carboxylase, decreasing malonyl-CoA. Lower malonyl-CoA disinhibits carnitine palmitoyltransferase-I (CPT-I), driving fatty acid beta-oxidation and massive ketone production.

The question specifically asks for the foundational biochemical mechanism responsible for the acid-base derangement.

Key Concept

Sodium-glucose cotransporter-2 (SGLT2) inhibitors can cause euglycemic diabetic ketoacidosis, driven by a low insulin-to-glucagon ratio that decreases malonyl-CoA levels, thereby disinhibiting carnitine palmitoyltransferase-I and promoting unregulated ketogenesis.

Question 1500Question →

A 62-year-old woman is evaluated for right upper quadrant abdominal pain and unintentional weight loss. Imaging reveals a 4-cm irregular breast mass and multiple hepatic lesions consistent with metastasis. Biopsy of the breast mass confirms invasive ductal carcinoma. The development of these distant hepatic metastases involves a complex, multi-step cascade of cellular and molecular changes. Arrange the following pathophysiologic steps of the metastatic cascade in the correct chronological sequence, beginning with the initial alteration in the primary breast tumor cells and ending with the establishment of the secondary hepatic tumor.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of the metastatic cascade is: E-cadherin downregulation, followed by basement membrane degradation, intravasation into the circulation, adherence to the distant endothelium, and finally extravasation with angiogenesis.

The metastatic cascade is a highly ordered series of biological events required for a primary tumor to spread to distant sites. It begins with the detachment of tumor cells from the primary mass, primarily mediated by the downregulation of E-cadherin. Detached cells then secrete proteolytic enzymes, such as matrix metalloproteinases (e.g., type IV collagenases), to degrade the basement membrane. This degradation allows the cells to invade the underlying extracellular matrix and intravasate into local blood or lymphatic vessels. Once in the systemic circulation, they must survive host immune defenses and physical shear stress, eventually adhering to the vascular endothelium of a distant organ, such as the liver. Finally, the cells extravasate into the target tissue parenchyma and must secrete pro-angiogenic factors, such as VEGF, to establish a vascular supply for the new metastatic colony.

Step-by-Step Solution

Identify the initial cellular change required for a carcinoma to metastasize.

Loss of intercellular adhesion.

Tumor cells must first detach from the primary tumor mass via E-cadherin downregulation before any invasion can occur.

Determine the physical barrier that must be crossed next.

Degradation of the basement membrane.

Epithelial tumors are separated from the vascularized stroma by a basement membrane, which must be enzymatically degraded by matrix metalloproteinases.

Identify the mechanism of entry into the systemic circulation.

Transmigration and intravasation.

Once the membrane is breached, cells migrate through the extracellular matrix and intravasate into the blood or lymphatic vessels.

Describe the necessary events within the systemic circulation.

Survival and adherence.

Tumor cells must survive shear stress and host immunity while traveling through the bloodstream, ultimately adhering to the vascular endothelium at the distant metastatic site.

Determine the final steps for establishing a viable secondary tumor.

Extravasation and angiogenesis.

Cells must exit the vessel into the target organ parenchyma and trigger angiogenesis to secure a nutrient supply, allowing growth beyond a microscopic size.

Key Concept

The metastatic cascade is a sequential process involving detachment (E-cadherin loss), invasion (metalloproteinases), intravasation, transport/adherence, extravasation, and angiogenesis.

PreviousPage 75 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept